Authorized Shares: 100,000,000 a/o Sept 01, 2017
Outstanding Shares: 11,552,000 a/o Sept 01, 2017
About Qrons Inc.
The company is a startup preclinical stage biotechnology company engaged in developing solutions to combat neuro-degenerative diseases and neuronal injuries. The company is working to develop a novel stem cell system to repair and regenerate neuronal damage. The system incorporates what we believe to be unique stem cell treatments, cell modifications and a novel delivery system. Our preliminary focus is on Traumatic Brain Injury, Parkinson's disease, Huntington's disease and Alzheimer's, although we believe such cell system can be effective in dealing with strokes and spinal cord injuries as well.